This is the classic website, which will be retired eventually. Please visit the modernized ClinicalTrials.gov instead.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Optimization of Surgical Treatment of Patients With Incisional Ventral Hernias

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT05734222
Recruitment Status : Recruiting
First Posted : February 17, 2023
Last Update Posted : February 17, 2023
Sponsor:
Information provided by (Responsible Party):
Samara State Medical University

Brief Summary:

The goal of our work of optimization of the treatment of postoperative hernias is to improve the results of treatment of patients with median and median-lateral postoperative hernias of medium (W2) and large (W3) sizes by developing new surgical techniques. The main questions it aims to answer are:

  1. To study the topographic and variant anatomy of vessels and nerves in the retromuscular, preperitoneal, postperitoneal and pre-abdominal cell spaces of the anterior abdominal wall. To determine the most probable sources of blood flow and lymph from the anatomical formations forming the bed of the endoprosthesis.
  2. To develop technical, surgical techniques that allow to form an implant bed with minimal traumatization of blood vessels and nerves and reduce the risk of postoperative complications.
  3. To develop a technique for plasty of the anterior abdominal wall in mid-lateral postoperative hernias with a combination of retromuscular and subaponeurotic spaces.

The researchers will compare an experimental group in which a new method of preparing the implant place will be used and a control group in which standard methods of treating postoperative ventral hernias were used to see whether the new method affects the improvement of the postoperative period and the reduction of complications.


Condition or disease Intervention/treatment Phase
Incisional Hernia Medial Hernia Medial-lateral Hernia Procedure: A new method of repair of the abdominal wall of mid-lateral postoperative ventral hernias Not Applicable

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 110 participants
Allocation: Non-Randomized
Intervention Model: Crossover Assignment
Intervention Model Description:

The study will include patients with postoperative ventral hernias of median and lateral localization and an average hernial gate width from 4.1 to 15 cm (W2-W3 according to the EHS classification).. The size of the hernial gate is determined by CT. The estimated number of patients is 60-80. 25-30 patients with median-lateral ventral postoperative hernias and 35-50 patients with median hernias are expected.

2. The control group is retrospective. It will include patients who have been operated on for POVG in the surgical department No. 1 of the KPH during the last 3 years (25-35) and 5-10 patients who will be operated on within the next 6-8 months.

3. The established group - patients who will be operated on in the surgical department No. 1 of the KPH over the next 1.5 - 2 years, using the developed techniques.

Masking: None (Open Label)
Masking Description:

4. The comparison groups will include patients who underwent retromuscular plastic surgery followed by aspiration drainage of the prosthesis bed. When analyzing the results, the presence of obesity and coagulopathy will be taken into account, CT and ultrasound examination will be carried out. Special attention will be paid to the presence and volume of liquid formations in the implant bed.

5. Immediate results will be evaluated up to 1 year Criteria for evaluating immediate results: treatment time, pain syndrome, the presence of seromas and hematomas, their infection and suppuration.

6. Long-term results will be evaluated in terms from 1 to 1.5 years. Evaluation criteria: the presence of recurrent hernia, the presence of late complications - fistulas, seromas requiring drainage, pain syndrome.

Primary Purpose: Treatment
Official Title: Optimization of Surgical Treatment of Patients With Postoperative Median and Median-lateral Ventral Hernias
Actual Study Start Date : September 29, 2022
Estimated Primary Completion Date : April 30, 2024
Estimated Study Completion Date : May 23, 2025

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Hernia

Arm Intervention/treatment
Active Comparator: Control Group
The control group is retrospective. It will include patients who have been operated on for POVG in the surgical department No. 1 of the KPH during the last 3 years (25-35) and 5-10 patients who will be operated on within the next 6-8 months.
Procedure: A new method of repair of the abdominal wall of mid-lateral postoperative ventral hernias
  1. It is planned to study potential sources of bleeding and hematoma formation during SRM plastic surgery. On this basis, recommendations on the technique of the operation will be formulated.
  2. It is supposed to find a way to preserve intercostal neurovascular bundles when performing SRM repair. This should improve the quality of abdominal wall reconstruction by preserving neurovascular bundles of muscles and reducing neuroalgic pain syndrome.
  3. It is proposed to develop a method for combining retromuscular and subaponeurotic spaces in the treatment of mid-lateral hernias
  4. It is planned to substantiate the effectiveness and expediency of the application of the developed surgical techniques based on the analysis of the immediate and long-term results of treatment.
Other Name: Development of techniques to minimize traumatization of the neurovascular bundles of the abdominal wall and reduce postoperative complications.

Experimental: Established group
The established group - patients who will be operated on in the surgical department No. 1 of the KPH over the next 1.5 - 2 years, using the developed techniques.
Procedure: A new method of repair of the abdominal wall of mid-lateral postoperative ventral hernias
  1. It is planned to study potential sources of bleeding and hematoma formation during SRM plastic surgery. On this basis, recommendations on the technique of the operation will be formulated.
  2. It is supposed to find a way to preserve intercostal neurovascular bundles when performing SRM repair. This should improve the quality of abdominal wall reconstruction by preserving neurovascular bundles of muscles and reducing neuroalgic pain syndrome.
  3. It is proposed to develop a method for combining retromuscular and subaponeurotic spaces in the treatment of mid-lateral hernias
  4. It is planned to substantiate the effectiveness and expediency of the application of the developed surgical techniques based on the analysis of the immediate and long-term results of treatment.
Other Name: Development of techniques to minimize traumatization of the neurovascular bundles of the abdominal wall and reduce postoperative complications.




Primary Outcome Measures :
  1. seroma [ Time Frame: from 3 to 5 days ]
    development of seroma in postoperative area

  2. hematoma [ Time Frame: from 3 to 5 days ]
    development of hematoma in postoperative area


Secondary Outcome Measures :
  1. Pus [ Time Frame: from 3 to 7 days ]
    development of suppuration in postoperative area



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   25 Years to 88 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • The study will include patients with postoperative ventral hernias of median and lateral localization and an average hernial gate width from 4.1 to 15 cm (W2-W3 according to the EHS classification).. The size of the hernial gate is determined by CT.

Exclusion Criteria:

  • Patients without postoperative ventral hernias median and lateral localization

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05734222


Contacts
Layout table for location contacts
Contact: Alexander Grigiryevich +79272024050 a.g.sonis@samsmu.ru
Contact: Vladislav Vladimirovich +79270004150 v.v.timoschuk@samsmu.ru

Locations
Layout table for location information
Russian Federation
Clinics of Samara State Medical University Recruiting
Samara, Russian Federation
Sponsors and Collaborators
Samara State Medical University
Layout table for additonal information
Responsible Party: Samara State Medical University
ClinicalTrials.gov Identifier: NCT05734222    
Other Study ID Numbers: 124537
First Posted: February 17, 2023    Key Record Dates
Last Update Posted: February 17, 2023
Last Verified: January 2023

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Samara State Medical University:
Incisional Hernia
median
median-lateral
median-lateral Incisional hernia
hernia
Incisional
Additional relevant MeSH terms:
Layout table for MeSH terms
Hernia
Incisional Hernia
Hernia, Ventral
Pathological Conditions, Anatomical
Postoperative Complications
Pathologic Processes
Hernia, Abdominal